November
It’s Not Rocket Science, It’s Pharma Marketing
Does it sometimes seem that healthcare marketers are light years away from understanding how ...
The Sunshine Act’s Crackdown on Medical Reprints—What Pharma Can Do About It
In an effort to create transparency between pharmaceutical companies and physicians, The Sunshine Act ...
Examining the Importance of IDNs: Where Their Influence Matters and Where it Doesn’t
Modern-day commercial success is no longer exclusively dependent on how many providers are actively ...
The Secret to Better Relationships with Hospitals and Health Systems Decision Makers
Four pharmaceutical and biotech companies—Merck, GlaxoSmithKline, Pfizer and Sanofi—have the most in-person meetings with ...
